The mechanism of estrogen-induced increase in hyaluronic acid biosynthesis, with special reference to estrogen receptor in the mouse skin.
The increase in hyaluronic acid and water contents induced by estradiol treatment in the mouse skin was dependent on dose and the number of treatments of estradiol. The anti-estrogen administered together with estradiol blocked the increase in hyaluronic acid content produced by treatment with estradiol alone. It was suggested that the anti-estrogen may act as an antagonist by competing for the cytoplasmic estrogen receptor on increase in hyaluronic acid synthesis. It was observed that the sensitivity in increase in hyaluronic acid biosynthesis by estradiol was related to the age of the mouse and the content of the cytoplasmic estrogen receptor in the mouse skin. It was suggested that there was a possible relationship between the increase in hyaluronic acid and cytoplasmic estrogen receptor in the mouse skin.
D000818:Animals; D001834:Body Water / Q000187:drug effects; D002996:Clomiphene / Q000494:pharmacology; D003871:Dermatan Sulfate / Q000096:biosynthesis; D004958:Estradiol / Q000494:pharmacology*; D006025:Glycosaminoglycans / Q000378:metabolism; D006820:Hyaluronic Acid / Q000096:biosynthesis*; D008297:Male; D051379:Mice; D011960:Receptors, Estrogen / Q000187:drug effects*; D012867:Skin / Q000187:drug effects*; D013629:Tamoxifen / Q000494:pharmacology
D006025:Glycosaminoglycans; D011960:Receptors, Estrogen; D013629:Tamoxifen; D002996:Clomiphene; D003871:Dermatan Sulfate; D004958:Estradiol; D006820:Hyaluronic Acid